Abstract. The present study investigates the mechanisms related to the endogenous nitric oxide synthase (eNOS) activation in the relaxant effects of a proanthocyanidin-rich fraction (PRF), obtained from Croton celtidifolius BAILL barks, in rat thoracic aorta rings with endothelium. In vessels pre-contracted with phenylephrine (Phe), PRF (0.1 -100 μg / mL) induced a concentration-dependent relaxation. This effect was significantly reduced by endothelium denudation, by N ω -nitro-L-arginine, and by 1H[1,2,3]oxadiazolo [4,3-alpha]quinoxalin. However, the vasorelaxant effect was not altered by indomethacin, atropine, tetraethylammonium, and charybdotoxin plus apamin. In thoracic aorta rings pre-contracted with phorbol-12,13-dibuyrate, PRF also induced a concentration-dependent relaxation. The PRF-induced relaxation disappeared in the absence of extracellular calcium in the medium and decreased significantly in the presence of lanthanum. A sulfhydryl alkylating agent, N-ethylmaleimide, and a phospholipase C (PLC) blocker, neomycin, significantly decreased PRF-induced vasorelaxation. In vessels pre-contracted with Phe, the PRFinduced vasorelaxant effect was not altered by quinacrine and ONO-RS-082, genistein and thyrphostin A-23, GF109203, and pertussis toxin and cholera toxin. The results suggest that the PRF-induced vasorelaxant effect is endothelium-dependent and involves the NO / cGMP pathway. We hypothesize that the activation of eNOS is due to an increase of intracellular calcium derived from PLC activation and an N-ethylmaleimide sensitive pathway.
Introduction
Croton celtidifolius is a tree from the Atlantic Forest, frequently found in the Southern region of Brazil (1) . In folk medicine, its bark is either chewed or taken as an infusion for the treatment of inflammatory and ulcerative diseases. Biological activities of C. celtidifolius include the: antiedematogenic, antioxidant (2), antiinflammatory, superoxide dismutase enzyme activity modulator (3), antinociceptive effect (4), with involvement of the dopaminergic pathway and participation of capsaicin-sensitive C-fibers (5, 6 ). Chemical studies demonstrate the presence of some compounds in C. celtidifolius, including cyclitols, 1L-1-O-methyl-mioinositol, neo-inositol, and sitosterol (7); catechins, gallocatechins, and proanthocyanidin (2, 6); alkaloids and saponins (8 -10) .
Proanthocyanidins present several properties such as antimicrobial, antiviral, antitumoral, antioxidant, antiinflammatory, anti-ulcer, and anti-diarrheal activity (11) . Many reports demonstrate the importance of proanthocyanidins on the cardiovascular system, including downregulation of the TNF-α-induced expression of VCAM-1, ICAM-1, and E-selectins; inhibition of platelet aggregation; and endothelium-dependent relaxation of blood vessels due to enhanced generation and / or increased biological activity of nitric oxide (NO) and NO synthase (NOS) expression (for a review, see ref. 12) .
The regulation of endogenous NOS (eNOS) activity is subject to carefully controlled activation and inactivation developed through multiple interconnected regulation mechanisms such as expression and transcription of NOS, subcellular localization (protein-protein interactions and acylation of eNOS), regulation of NOS enzymatic activity by effects on the NOS protein (calcium / calmodulin and reversible palmitoylation), phosphorylation, and S-nitrosylation (13, 14) . It has been conceptualized that the major pathway for NO production involves Ca 2+ mobilization that results in elevating intracellular free calcium and activation of eNOS (15) and that the increased NO production in the endothelial cells coincides with the elevation of [Ca 2+ ] i (16) 
. Increases in intracellular calcium concentration ([Ca
] i ) are due to mobilization of Ca 2+ from intracellular stores and Ca 2+ entry via voltage-independent cationic channels (17, 18) . Mobilization of Ca 2+ from intracellular and extracellular sources was reported to be associated with stimulation of phospholipase C (PLC), phospholipase A 2 (PLA 2 ), tyrosine kinase, or protein kinase (PKC) activity, secondary to a receptor-dependent or -independent pathway (19, 20) .
In a recent study, we observed that proanthocyanidinrich fraction (PRF) mediates an endothelium-dependent vasorelaxant effect involving the NO-cGMP pathway and hyperpolarization induced by K Ca2+ channels activation in rat small resistance arteries (21) . The aim of the current investigation is to determine the mechanisms of the PRF-induced vasodilator effect, using rat thoracic aorta. This paper focused on the role of endotheliumderived products, the sources of Ca 2+ , the involvement of G-proteins, the role of PLC, PLA 2 , tyrosine kinase, and PKC as to their relative contribution to the PRF-induced vasorelaxant effect.
Materials and Methods

Plant material
Bark of C. celtidifolius BAILL. was collected from the forest surrounding the city of Orleans (State of Santa Catarina, Brazil) and a voucher specimen (document number 31272) was identified and deposited both at the Department of Botany, UFSC, and in the author's laboratory.
Air-dried powdered bark of C. celtidifolius was extracted by exhaustive percolation with 80% aqueous EtOH at room temperature. The solvent was vacuumremoved and the crude extract was dissolved in acetone to obtain a saturated solution. Then, a large volume of water was added causing precipitate formation. This precipitate was removed by filtration and the solution was transferred to a Rota-vapor for acetone elimination. The resultant aqueous solution was extracted with EtOAc and after the organic solvent removal, a PRF was provided. This indicates a yield of 0.56% of PRF from the original material (air-dried bark).
Characterization of PRF
Phytochemical investigation performed by column chromatography fractionation, following NMR spectral analysis of the isolated compounds, together with micellar electrokinetic chromatography (MEKC) analyses showed that the PRF fraction contains 27.4% catechin, 1.3% epicatechin, 6.4% gallocatechin, 16.7% catechin-(4α→8)-catechin, 4.9% gallocatechin-(4α→8)-catechin, and 43.3% proanthocyanidin oligomers. Further thiolysis of the PRF following MECK demonstrated that proanthocyanidin oligomers are mainly composed of catechin and epicatechin units in the ratio of 1.5 to 1.
All capillary electrophoresis (EC) experiments were performed on an Agilent Technologies HP 3D CE apparatus (Palo Alto, CA, USA), equipped with a diode array detector set at 207 nm. The measurements were performed at 25°C on an uncoated fused-silica capillary (60 cm × 50 μm I.D. × 375 μm O.D.) obtained from Polymicro Technologies (Phoenix, AZ, USA). Amid runs, the capillary was rinsed for 2 min with running buffer. Samples were introduced from the outlet capillary extremity and injected hydrodynamically at 50 mbar for 6 s (50 mbar = 4996.2 Pa) with negative pressure. The applied separation voltage was 20 kV, in positive polarity. Data acquisition and the treatment were performed with HP Chemstation software (Ontario, Canada).
The PRF thiolysis followed the procedure of HerreroMartinez and colleagues (22) . PRF (10 mg) was dissolved in methanol (1 mL). An aliquot (200 μL) was added to the thiolysis mixture (200 μL), which consisted of cysteine hydrochloride (50 mg) and 37% hydrochloric acid (20 μL) dissolved in methanol (930 μL). The mixture (400 μL) was kept at 65°C for 20 min, and then the reaction was quenched with 0.1% v / v aqueous TFA (1.2 mL). The samples were properly diluted with this TFA solution and injected into the capillary electrophoresis system.
Animals
Male Wistar rats (250 -350 g) were used in all experiments. The animals were kept at 22 ± 2°C under a 12-h light / 12-h dark cycle and with free access to food and water. The experiments were performed after approval of the protocol by the institutional Ethics Committee (n° pp00105 / CEUA) and were carried out in accordance with the guidelines of our university.
Tissue preparation
Thoracic aorta was isolated as described previously by Andriambeloson and colleagues (20) . In brief, rats were killed by exposure to CO 2 and exsanguinated. The thoracic aorta was carefully removed and cut into rings 3 -4 mm in length and pinned in a dissecting dish containing Krebs-Henseleit solution. The arteries were cleaned of fat and connective tissue and mounted using two wires inserted through the lumen of the vessel in an organ chamber in Krebs-Henseleit solution of the following composition:113 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl 2 , 0.9 mM KH 2 PO 4 , 25 mM NaHCO 3 , 1.1 mM MgCl 2 , and 11 mM glucose, pH 7.4, maintained continuously gassed with 95% O 2 -5% CO 2 and at 37°C, and under a resting tension of 1 g. Mechanical activity was recorded isometrically by a power transducer connected to an amplifier and chart recorder (Soft and solutions -KITCAD8). In some experiments, the endothelial layer was mechanically removed immediately after the dissection. The PRF-induced vasorelaxant effect was expressed as the percentage reduction in the Phe-induced increase in tone above baseline.
Experimental protocol
After an equilibration period of 60 min, rings were pre-contracted with Phe (1 μM) and the presence of functional endothelium was assessed by the ability of acetylcholine (ACh) (1 μM) to induce more than 75% relaxation of vessels pre-contracted with Phe. The absence of a relaxation response to ACh was taken as evidence that the artery segments were functionally denuded of endothelium. After testing the functional endothelium, rings were precontracted to submaximal contraction with either Phe (1 μM) or phorbol-12,13-dibutirate (PDBU, 15 -20 nM). After the contractile response reached an area of stability, the PRF-induced vasorelaxant activity (0.1 -100 μg/ mL) was tested. The participation of functional endothelium in the PRFinduced relaxant effect in some experiments was conducted with rings without endothelium.
In order to verify the participation of endotheliumderived products in the PRF-induced vasorelaxant effect (0.1 -100 μg/ mL), experiments were performed in the presence of the NOS inhibitor N ω -nitro-L-arginine (L-NOARG, 10 μM); the guanylyl cyclase inhibitor H [1, 2, 3] oxadiazolo [4,3-alpha] quinoxalin (ODQ, 1 μM); the cyclooxygenase (COX) inhibitor indomethacin (1 μM); the muscarinic antagonist atropine (1 μM); a nonselective K + channels blocker, tetraethylammonium (TEA, 500 μM); and charybdotoxin (ChTx, 100 nM) plus apamin (APA, 100 nM), inhibitors of Ca 2+ -dependent K + channels. The drugs were added to the bath 20 min prior to addition of Phe.
The involvement of extracellular Ca 2+ in the PRFinduced relaxation (0.1 -100 μg / mL) was assessed in preparations with or without CaCl 2 in the medium, or in the presence of lanthanum (100 μM), a Ca 2+ blocker, in vessels precontracted with PDBU (15 and 20 nM in the presence and the absence of Ca 2+ , respectively). Lanthanum was added to the bath 20 min prior to addition of PDBU. For Ca 2+ -free medium, CaCl 2 was omitted, and 0.1 mM EGTA was added. The effect of N-ethylmaleimide (NEM, 10 μM), a sulphydryl alkylating agent, on the PRF-induced vasorelaxation (0.1 -100 μg / mL) was investigated in vessels precontracted with PDBu (15 nM). NEM was added 10 min before precontraction with PDBu.
We also studied the role of the PLC pathway in PRF-induced vasorelaxation. Neomycin (1 mM), a PLC inhibitor, was added to the bath 15 min before PDBu (15 nM).
In another group of experiments, the involvement of G protein was investigated by testing the effect of either pertussis toxin (PTx) and cholera toxin (CTx) treatment on the PRF-induced relaxation (0.1 -100 μg / mL). Rings were incubated for 12 h at 37°C in Dulbecco's modified Eagle's medium-nutrient with 15% fetal bovine serum containing 600 ng / mL of either PTx or CTx in a 5% CO 2 humidified atmosphere. In control experiments, aortic rings were incubated with toxin-free medium under the same conditions.
The role of the PLA 2 pathway was investigated by using quinacrine (10 μM) or ONO-RS-082 (1 μM); the involvement of different protein kinases was tested by using the PKC inhibitor GF109203X (5 μM) or tyrosine kinase inhibitors tyrphostin A-23 (30 μM) and genistein (30 μM). All the inhibitors were incubated for 20 min before the precontraction with Phe (1 μM), that was used in this set of experiments (20) .
Drugs
The following compounds were utilized: Dulbecco's Modified Eagle's Medium, phosphate-buffered saline (PBS), dimethyl sulfoxide, ethanol, indomethacin, atropine, L-NOARG, Phe, TEA, PDBU, quinacrine, genistein, lanthanum, NEM, PTx, CTx, neomycin, ODQ, ChTx, and APA were purchased from Sigma (St. Louis, MO, USA). Heparin was purchased from Roche (Rio de Janeiro, Brazil); ONO-RS-082, from BIOMOL Research Laboratories, Inc. (Campus Drive, Plymouth Meeting, PA, USA); thyrphostin A-23, from Calbiochem (Nottingham, UK), and GF109203X, from Tocris Cookson, Inc. (Langford, Bristol, UK). All drug solutions were freshly prepared before each experiment and were dissolved in PBS, except genistein, GF109203X, and ONO-RS-082 which were dissolved in 0.2% dimethyl sulfoxide, NEM and PDBU were first dissolved in ethanol and heparin and then afterwards dissolved in saline. The PRF was dissolved in distilled water.
Statistical analysis
The results were each expressed as a mean ± S.E.M. Statistical comparisons between groups were carried out using one-way analysis of variance (ANOVA) followed by the Student-Newman-Keuls test. Differences with P-values less than 0.05 (P<0.05) were considered statistically significant.
Results
In intact thoracic aorta rings pre-contracted with Phe, PRF (0.01 -100 μg / mL) induced a concentrationdependent vasodilator effect. However, in vessels without endothelium, PRF was not able to produce relaxation (Fig. 1) . In order to investigate whether the vasodilator effect of PRF was dependent on endothelium-derived products, cumulative concentration-response curves (CRCc) were obtained for PRF in the presence of indomethacin (1 μM), atropine (1 μM), TEA (500 μM), and ChTx (100 nM) plus APA (100 nM), which did not change the vasodilator effect of the fraction as shown in Fig. 2 and Table 1 . However, pretreatment of vessels with the NOS inhibitor L-NOARG (10 μM) and guanylyl cyclase inhibitor ODQ (1 μM) reduced the PRF-induced vasodilator effect by 100% and 95%, respectively ( Fig. 3 and Table 1 ).
In vessel PDBu-precontracted, PRF produced comparable relaxation in thoracic aorta rings with endothelium when compared with those precontracted with Phe (56.8 ± 5.2%) (Fig. 4) . The PRF-induced relaxation disappeared in the absence of extracellular calcium in the medium and decreased significantly in the presence of the calcium entry blocker, lanthanum (100 μM) (Fig. 4 and Table 2 ). The sources of extracellular calcium involved in the PRF-induced relaxation were studied by testing its effects in the presence of several drugs. The sulfhydryl alkylating agent NEM (10 μM) and the PLC blocker.
Neomycin (1 mM) significantly decreased the PRFinduced vasorelaxant effect as shown in Fig. 5 and Table 2 .
In order to investigate whether the mechanism by which the PRF triggers its vasodilator effect occurred mainly by the PLA 2 pathway, vessels were incubated with quinacrine and ONO-RS-082, two PLA 2 inhibitors, and pre-contracted with Phe (1 μM). The results indicated that both inhibitors failed to reduce the PRFinduced vasorelaxant effect ( Fig. 6 and Table 1 ). The thyrosine kinase inhibitors genistein and thyrphostin A-23 also failed to produce any reduction in PRF-induced relaxation in the vessel precontracted with Phe (1 μM), as shown in Fig. 6 . PRF CRCc was obtained in the presence of the protein kinase C inhibitor GF109203 (5 μM) in vessels precontracted with Phe (1 μM). The pretreatment of thoracic aorta rings was not able to produce any change to the PRF-induced vasodilation ( Fig. 6 and Table 1 ).
In the rings incubated for 12 h in Dulbecco's modified Eagle's medium-containing 600 ng / mL of either PTx (600 ng / mL) or CTx (600 ng / mL), pre-contracted with Phe (1 μM), the PRF-induced vasodilator effect was not changed, when compared to the control group ( Fig. 7 and Table 3 ).
Discussion
The main objective of this study was to investigate the mechanisms underlying the endothelium-dependent relaxation response to PRF in pre-contracted rat thoracic aorta rings. The results showed clearly that the vasorelaxant response to PRF is endothelium-dependent and mediated predominantly by activation of the NO / cGMP pathway and prostaglandin pathway due to an influx of extracellular calcium derived from the PLC activation and an NEM-sensitive pathway.
In the cardiovascular system, endothelial cells play key regulatory roles by producing several potent vasoactive agents and regulating coagulation states (23, 24) . Vasodilation regulation by endothelium is achieved with three main components: NO, prostacyclin, and endothelium-derived hyperpolarizing factor (EDHF) (25) . Prostacyclin is a prostanoid produced by the COX pathway that relaxes vascular smooth muscle by activating IP receptors, leading to an increase in cAMP. Prostacyclin stimulates PCA, activating sarcoplasmic reticulum Ca
2+
-ATPase, which in turn is responsible for the Ca 2+ uptake from the intracellular medium to the sarcoplasmic reticulum (26, 27) . The involvement of prostaglandins in the vasodilator effect of PRF in aorta relaxation does not seem likely since the non-specific COX inhibitor indomethacin affects responses to PRF.
Vasodilator substances and shear stress induce varying degrees of hyperpolarization of the plasma membrane of endothelial cells, which is a response that reflects on the activation of endothelial K + channels. This hyperpolarization would induce relaxation by reducing the open probability of voltage-dependent Ca 2+ channels, thereby decreasing Ca 2+ influx and lowering intracellular Ca 2+ levels. Alternatively, the hyperpolarization may reduce the intracellular phosphatidylinositol turnover stimulated by agonist-induced receptor activation (28, 29) . Moreover, activation of a smallconductance Ca
-dependent K + channel contributes to agonist-induced stimulation of nitric oxide synthesis (30) . The mechanism by which PRF induces endothelial vasorelaxation could not be attributed to K + channels since a nonselective K + channel blocker (TEA) and inhibitors of Ca 2+ -activated K + channels (ChTx plus APA) failed to inhibit the PRF-induced vasorelaxant effect.
The NO-cGMP pathway plays an important role in the regulation of vascular tone and the control of blood flow and arterial pressure (31) . NO mediates physiological responses in the endothelium itself as well as in other target cells by mechanisms that include activation of the heme-containing soluble guanylate cyclase (32) . + CTx (600 ng /mL) 75.5 ± 9.6
Mean ± S.E.M.
In vascular smooth muscle, an elevation of cGMP, acting through protein kinase G, inhibits the activation of PLC, stimulates the plasmalemmal Ca 2+ pump, and lowers the Ca 2+ sensitivity of the contractile proteins (33), leading to blood vessel dilation. In this study, we clearly indicate that the PRF-induced vasodilator effect depends on the activation of the NO-cGMP pathway, since the L-NOARG, an inhibitor of NOS, and ODQ, an inhibitor of guanylate cyclase, significantly reduced the effect of PRF in rat thoracic aorta. In this way, PRF may stimulate the endothelial NO system and induce further relaxation of vascular smooth muscle through the increase of cGMP in these cells.
Nitric oxide can be released from endothelial cells by activation of many different membrane-receptors (34, 35) . The PRF-induced vasodilator effect is not dependent on receptor activation by ACh, since pretreatment with atropine did not reduce the PRF-induced vasodilator effect. It was proposed that G proteins may play a role in the mechanism leading to Ca 2+ entry and the subsequent production of vasoactive agents (36) such as NO (18, 37, 38) . For this reason, we investigated the possible implication of G proteins in the PRFinduced vasorelaxant effect using PTx and CTx. The results showed that neither PTx nor CTx affect the response to PRF, suggesting that PTx and CTx-sensitive G proteins are not involved in PRF-induced vasorelaxation. The involvement of G-protein insensitive to both PTx and CTx cannot be excluded.
NEM is a sulfhydryl alkylating agent that can alkylate various plasma membrane proteins. However, NEM was described to be capable of inactivating G proteins with some degree of selectivity over cellular structures at the concentration <10 μM. In our study, treatment of the vessels with NEM abolishes the response of PRF, suggesting the involvement of the G-protein in the PRF-induced vasorelaxant effect. However, the possibility for NEM to alkylate other plasma membrane proteins, including plasma membrane Ca 2+ channels, cannot be excluded. The possible channels involved for Ca 2+ entry in the endothelial cells are those opened subsequent to Ca 2+ -store depletion, which can be stimulated by agonists such as ACh (20, 39) .
Most endothelial functions depend, to various extents, on changes in [Ca 2+ ] i (23) . It has been conceptualized that the major pathway for NO production involves Ca 2+ mobilization, which results in elevating intracellular free calcium and activation of eNOS (15, 40, 41) . The agonist-stimulated release of NO from endothelial cells, such as bradykinin and ACh, is mediated predominantly by a calcium-calmodulin-dependent mechanism (23, 40, 42) and requires substantial influx of extracellular Ca 2+ to stimulate eNOS (43) , to produce NO and subsequently to promote endothelium-dependent vasorelaxation. For example, when agonists, such as bradykinin or ACh, are used to stimulate endothelial NO production, either the chelation of extracellular calcium or the addition of a calmodulin antagonist abolishes NO production and endothelium-dependent relaxation (42) . In our results, we demonstrate that the PRF-induced vasorelaxation was prevented after removal of extracellular Ca 2+ in the medium and in the presence of the Ca
-entry blocker lanthanum, suggesting that the Ca 2+ influx is the critical step involved in this effect. However, we cannot exclude the possible role of involvement of Ca 2+ released from intracellular stores in endothelial NO-depended relaxation produced by PRF.
In endothelial cells, the Ca 2+ entry may occur via several pathways. Calcium can be released from intra- Fig. 8 . Schematic diagram showing likely mechanisms by which the proanthocyanidin-rich fraction (PRF) leads to nitric oxide (NO) release from endothelium: PRF mediates the activation of protein G-coupled receptor (R) and subsequent activation of phospholipase C (PLC). PLC can stimulate calcium release from intracellular stores and cause the activation of eNOS. PRF can also activate plasma membrane Ca 2+ channels, which induce the calcium entry from the extracellular medium, resulting in elevation of intracellular free calcium and activation of eNOS. GTP, guanosine triphosphate; cGMP, cyclic guanosine monophosphate; IP3, inositol(1,4,5)-triphosphate; NOS, nitric oxide synthase. cellular stores by inositol 1,4,5-triphosphate (IP 3 ), which is formed by the action of PLC (41) . Findings suggest the participation of PLC in the PRF-induced vasorelaxant effect f PRF. This indicates that the fraction induces the activation of PLC, which results in the increase of intracellular calcium and subsequently eNOS activation. Other pathways involved in calcium entry in endothelial cells include the PLA 2 pathway and tyrosine kinase activation (20) . In this study, none of the specific inhibitors of each different pathway significantly altered the PRf-induced vasorelaxant effect, suggesting that PRF-induced endothelial NO production is unlikely to be related to the PLA 2 pathway and phosphorylation of intracellular proteins via PKC and tyrosine kinase enzymes.
In conclusion, this study demonstrates that the PRF, obtained from the bark of C. celtidifolius, mediates an endothelium-dependent vasorelaxant effect in rat thoracic aorta, which involves the activation of the NO-cGMP pathway through an extracellular calcium mechanism via a NEM-sensitive pathway and intracellular calcium mechanism via PLC activation (Fig. 8) . Since proanthocyanidins are not toxic to humans, evaluation of their clinical efficacy for potential application for the prevention and treatment of cardiovascular diseases is a relevant matter because this plant enhances endothelial function by formation of vasoprotective endothelial factors.
